Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update

Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – December 12, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases…